PATH  [to 8 July 2017]
Announcement |
PATH congratulates Dr. Brenda Fitzgerald on her appointment as the director of the US Centers for Disease Control and Prevention
July 06, 2017
[See appointment announcement above in Milestones]
MSF/Médecins Sans Frontières  [to 8 July 2017]
Press release
G20 Leaders Must Take Action to Protect Medical Facilities, Tackle Drug-Resistant Infections Including TB, and Better Prepare for Medical Emergencies
July 06, 2017
Ahead of the G20 summit in Hamburg, where global health is on the agenda for the first time, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) called on G20 leaders to follow through on the declaration made by their health ministers in late May.
[See excerpt from G20 Leaders’ Declaration above in Milestones]

Wellcome Trust  [to 8 July 2017]
Opinion / Published: 7 July 2017
G20 summit: act now in the fight against epidemics
The G20 summit starts today in Hamburg. As world leaders sit down for talks, Jeremy Farrar, Wellcome’s Director, and Paul Stoffels, Chief Scientific Officer of Johnson & Johnson, urge them to keep up the momentum in tackling infectious disease outbreaks.
[See excerpt from G20 Leaders’ Declaration above in Milestones]

News / Published: 6 July 2017
Longitudinal population studies: we’re streamlining our funding
We’re pleased to announce that we’re implementing a new strategy for funding longitudinal population studies. This includes cohorts, panel surveys and biobanks.
It means a new funding mechanism by the end of 2017, and an emphasis on how we can do more to promote and support data sharing between studies.
Until then, we’re not accepting applications for core support of longitudinal population studies.
Mary De Silva, Head of Population Health at Wellcome, says: “Longitudinal population studies are a vital resource for researchers. They gather data over a long period of time and often develop in unanticipated ways, providing value that can’t always be predicted.
“We’ve been funding ground-breaking longitudinal population studies for years. Our new strategy will help us fund in a more coherent way and support resources which integrate data from different sources to answer new research questions.”…


GHIT Fund   [to 8 July 2017]
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that devastate the world’s poorest people. Other funders include six Japanese pharmaceutical ·
2017.07.05      News
Open Letter to G20 – Global Health Innovation and Sustainable Development
[See excerpt from G20 Leaders’ Declaration above in Milestones]
FDA [to 8 July 2017]
July 07, 2017 –
FDA approves new treatment for sickle cell disease
First approval for this rare blood disorder in nearly 20 years
European Medicines Agency  [to 8 July 2017]
EMA and EUnetHTA step up interaction to align data requirements
A new joint platform for parallel consultation will provide advice to medicine developers and facilitate access to medicines for patients

UNAIDS  [to 8 July 2017]
Selected Press Releases & Updates
Latin American and Caribbean countries endorse bold commitments
06 July 2017
Latin American and Caribbean countries have adopted the Santiago Commitment to Action for the Implementation of the Global Strategy for Women’s, Children’s and Adolescent’s Health. The Santiago Commitment to Action, which was adopted at the Every Woman, Every Child, Every Adolescent meeting held in Santiago de Chile from 2 to 4 July, saw the countries agree to work to end all preventable deaths, including AIDS-related deaths of women, children and adolescents by 2030, and to develop effective initiatives to ensuring their well-being.

Armenia receives award for elimination of mother-to-child transmission of HIV
Ensuring healthy lives and promoting well-being for all at all ages.

BRICS health ministers agree to strengthen health systems to respond to HIV
06 July 2017
Health ministers from the BRICS countries (Brazil, the Russian Federation, India, China and South Africa) have agreed to strengthen their surveillance capacity and health-care services to respond to infectious diseases, such HIV, tuberculosis and malaria. They adopted a joint communiqué during the opening ceremony of the BRICS high-level meeting on traditional medicine, which is being held in Tianjin, China, on 6 and 7 July.

Press statement
African Union endorses major new initiatives to end AIDS
GENEVA, ADDIS ABABA, 3 July 2017—African heads of state have endorsed two major new initiatives to help end AIDS by 2030. The community health workers initiative aims to recruit, train and deploy 2 million community health workers across Africa by 2020. The western and central Africa catch-up plan aims to rapidly accelerate access to HIV treatment in the region and close the gap in access between African regions. The initiatives were endorsed at the AIDS Watch Africa Heads of State and Government Meeting, held on 3 July during the 29th African Union Summit in Addis Ababa, Ethiopia.

Global Fund [to 8 July 2017];&country=
Dr. Jeremiah Chakaya Elected New Chair of Technical Review Panel
06 July 2017
The Technical Review Panel, a pool of independent experts who analyze the technical merit of all funding applications to the Global Fund, has elected a new chair, Dr. Jeremiah Chakaya Muhwa, a world-renowned expert in tuberculosis from Kenya.
The Medicines Patent Pool Governance Board Appoints Marie-Paule Kieny as New Chair
Former World Health Organization Assistant Director-General brings more than four decades of experience in public health systems and innovation to the MPP
Jul 03, 2017, 05:00 ET
GENEVA, July 3, 2017 /PRNewswire/ — The Medicines Patent Pool (MPP) Governance Board today announced the appointment of Dr. Marie-Paule Kieny as its new chair, effective 1 September 2017. Dr. Kieny, the World Health Organization (WHO)’s former Assistant Director-General for Health Systems and Innovation, succeeds Sigrun Møgedal, chair since March 2016 and Charles Clift, the MPP’s founding chairman. She will lead a nine-member board in guiding the foundation’s voluntary licensing and patent pooling work in HIV, hepatitis C and tuberculosis…
EDCTP    [to 8 July 2017]
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
6 July 2017
EDCTP is launching 11 calls for proposals in 2017 to support clinical research and capacity building in sub-Saharan Africa. These calls represent a total investment of more than € 156.5M to tackle poverty-related diseases (PRDs), including neglected ones.
The calls for proposals are part of the EDCTP work plan for 2017 which was approved by the General Assembly (GA) of the EDCTP Association on 23 May 2017. The European Commission approved it on 3 July 2017, and EDCTP Association Board approved it on behalf of the GA on 5 July 2017.